Sun Pharmaceutical Industries reported a 46.5 percent drop in quarterly net profit after it set aside Rs 584 crore towards a possible compensation in a patent dispute case related to drug Protonix.
The Mumbai-based drugmaker said consolidated net profit fell to Rs 320 crore during fiscal second quarter ended September from Rs 598 crore a year earlier. Net sales rose 40.2 percent to Rs 2,657 crore.
Analysts had estimated the net profit at Rs 768 crore, according to Thomson Reuters I/B/E/S.
(Copyright Thomson Reuters 2012)
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
